FDA approves first Android app for CGM
The FDA has approved the Dexcom G5 mobile app for Android devices, the first continuous glucose monitoring platform available for Android devices in the United States, according to a press release from the company.
Beginning in June, Android users will have access to the free app for the Dexcom G5 Mobile CGM System, allowing people with diabetes to view and monitor their glucose levels on their mobile devices to manage their diabetes in real time. The Android app complements the 2015 app available for iOS.
The Dexcom G5 Mobile is a compact CGM system that works to display real-time glucose activity on certain approved display devices.
“Providing Android users with access to the Dexcom G5 Mobile CGM System has been a priority for Dexcom,” Kevin Sayer, president and CEO of Dexcom, said in a statement. “The new Android app has been thoughtfully designed with customer needs and feedback in mind. It focuses on delivering technology that empowers users by putting critical glucose information on their phones and is compatible with the most popular Android devices currently in the market.”
In December, the FDA approved an expanded indication for DexCom’s G5 Mobile Continuous Glucose Monitoring System to replace fingerstick blood glucose testing for people aged 2 years and older with diabetes.
The Dexcom G5 Mobile app for Android will initially be available on several Android devices from Samsung, Motorola and LG, as well as Android Wear watches. A current list of compatible devices can be found at www.dexcom.com/compatibility.